Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Terrascend Corp TSNDF


Primary Symbol: T.TSND

Healthcare Cannabis
TerrAscend Corp. is a Canada-based cannabis company. The Company has vertically integrated licensed operations in Pennsylvania, New Jersey, Maryland, Michigan and California through TerrAscend Growth Corp. and retail operations in Canada through TerrAscend Canada Inc. (TerrAscend). TerrAscend operates The Apothecarium, Gage and other dispensary retail locations as well as scaled cultivation... see more

Recent & Breaking News (TSX:TSND)

TerrAscend Reports Third Quarter 2024 Financial Results

GlobeNewswire November 6, 2024

TerrAscend Enters Ohio with the Signing of Definitive Agreement to Acquire a Well Situated and Profitable Dispensary

GlobeNewswire November 6, 2024

TerrAscend to Host Third Quarter 2024 Earnings Conference Call

GlobeNewswire October 7, 2024

TerrAscend Closes on Remaining US$26 Million Draw of US$140 Million Debt Financing

GlobeNewswire October 1, 2024

TerrAscend to Participate in the ATB Capital Markets 2024 Life Sciences Institutional Investor Conference on September 18th in NYC

GlobeNewswire September 5, 2024

TerrAscend Announces $10 Million Share Repurchase Program

GlobeNewswire August 20, 2024

TerrAscend Reports Second Quarter 2024 Financial Results

GlobeNewswire August 8, 2024

TerrAscend Completes $140 Million Debt Financing

GlobeNewswire August 2, 2024

TerrAscend to Host Second Quarter 2024 Earnings Conference Call

GlobeNewswire July 10, 2024

TerrAscend Announces Results of Annual General Meeting

GlobeNewswire June 17, 2024

TerrAscend Celebrates Opening of The Apothecarium Nottingham, Maryland Dispensary

GlobeNewswire June 10, 2024

TerrAscend Celebrates the Opening of its New Detroit Dispensary, GAGE 313

GlobeNewswire May 29, 2024

TerrAscend Announces May Conference Participation

GlobeNewswire May 14, 2024

TerrAscend Reports First Quarter 2024 Financial Results

GlobeNewswire May 9, 2024

Canadian Investment Regulatory Organization Trade Resumption - TSND

Canada NewsWire April 30, 2024

Canadian Investment Regulatory Organization Trading Halt - TSND

Canada NewsWire April 30, 2024

Sometimes Legends Come in Small Packages

GlobeNewswire April 24, 2024

TerrAscend to Host First Quarter 2024 Earnings Conference Call

GlobeNewswire April 4, 2024

TerrAscend Reports Fourth Quarter and Full Year 2023 Financial Results

GlobeNewswire March 14, 2024

TerrAscend to Host Fourth Quarter and Full Year 2023 Earnings Conference Call

GlobeNewswire February 20, 2024